CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 176 filers reported holding CLOVIS ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,614,000 | -46.3% | 106,335 | -30.8% | 0.54% | -38.3% |
| Q4 2017 | $10,454,000 | +51.5% | 153,735 | +83.6% | 0.87% | +88.5% |
| Q3 2017 | $6,900,000 | +599.8% | 83,735 | +694.8% | 0.46% | +579.4% |
| Q2 2017 | $986,000 | -2.6% | 10,535 | -33.7% | 0.07% | +6.2% |
| Q1 2017 | $1,012,000 | +44.2% | 15,900 | +0.6% | 0.06% | +36.2% |
| Q4 2016 | $702,000 | -29.2% | 15,800 | -42.5% | 0.05% | -9.6% |
| Q3 2016 | $991,000 | – | 27,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |